Back to Search Start Over

Characterization of antibody response in neuroinvasive infection caused by Toscana virus

Authors :
Giada Rossini
Rémi N. Charrel
Vittorio Sambri
Silvia Morini
P. Cenni
Caterina Vocale
Nazli Ayhan
M. P. Landini
Anna Pierro
Paolo Gaibani
Stefania Varani
Michele Bartoletti
Antonio Mastroianni
F. Prati
Luigi Raumer
S. Schivazappa
Russell E. Lewis
S. Ficarelli
CRREM Laboratory [Bologna, Italy] (Unit of Microbiology)
University hospital - Policlinico S.Orsola-Malpighi [Bologna, Italy]
Unit of Microbiology [Pievesestina, Italy] (The Romagna Hub Laboratory)
The Romagna Hub Laboratory [Pievesestina, Italy]
Emergence des Pathologies Virales (EPV)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Department of Medical and Surgical Science [Bologna, Italy] (Infectious Disease Unit)
University of Bologna/Università di Bologna
Infectious Disease Unit [Forlì, Italy]
G.B. Morgagni-Pierantoni Hospital [Forlì, Italy]
Infectious Disease Division [Reggio Emilia, Italy]
Reggio Emilia Hospital [Italy]
Emergency Department [Imola, Italy]
Imola Hospital S. Maria della Scaletta [Imola, Italy]
Department of Experimental, Diagnostic and Specialty Medicine [Bologna, Italy] (DIMES)
Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO)
This work was supported by the University of Bologna (RFO2013e2015 to SV, MPL) and by the Emilia-Romagna Region (Lab P3 funds). This work was also supported in part by the European Virus Archive goes Global (EVAg) project that has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 653316 (to RNC), the EDENext FP7- n261504 EU project (to RNC) and this paper is catalogued by the EDENext Steering Committee (http://www.edenext.eu) as EDENext467. The work of RNC was done under the frame of EurNegVec COST Action TD1303.
European Project: 653316,H2020,H2020-INFRAIA-2014-2015,EVAg(2015)
European Project: 261504,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,EDENEXT(2011)
University of Bologna
BUISINE, Soline
European Virus Archive goes global - EVAg - - H20202015-04-01 - 2019-03-31 - 653316 - VALID
Biology and control of vector-borne infections in Europe - EDENEXT - - EC:FP7:HEALTH2011-01-01 - 2015-06-30 - 261504 - VALID
Pierro, A.
Ficarelli, S.
Ayhan, N.
Morini, S.
Raumer, L.
Bartoletti, M.
Mastroianni, A.
Prati, F.
Schivazappa, S.
Cenni, P.
Vocale, C.
Rossini, G.
Gaibani, P.
Sambri, V.
Landini, M.P.
Lewis, R.E.
Charrel, R.N.
Varani, S.
Source :
Clinical Microbiology and Infection, Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (11), pp.868-873. ⟨10.1016/j.cmi.2017.03.017⟩
Publication Year :
2017
Publisher :
HAL CCSD, 2017.

Abstract

Among sandfly-borne pathogens, Toscana virus (TOSV) is a prominent cause of summer meningitis in Mediterranean Europe. Here, we assessed the kinetics of anti-TOSV antibodies over time in 41 patients diagnosed with TOSV-meningitis or meningoencephalitis in North-eastern Italy. Objectives: Among sandfly-borne pathogens, Toscana virus (TOSV) is a prominent cause of summer meningitis in Mediterranean Europe. Here, we assessed the kinetics of anti-TOSV antibodies over time in 41 patients diagnosed with TOSV meningitis or meningoencephalitis in northeastern Italy. Methods: Acute and follow-up serum samples were collected up to 20 months after diagnosis of TOSV infection and tested for the presence of specific antibody using immunoenzymatic and indirect immunofluorescence assays. In addition, maturation of anti-TOSV IgG over time was evaluated as well as production of neutralizing antibodies. Results: Specific IgM and IgG response was present at diagnosis in 100% of patients; TOSV-specific IgM and IgG were detected in patients' sera up to 6 and 20 months after diagnosis, respectively. The avidity index (AI) increased over the first month after infection in 100% of patients and most cases exceeded 60% by Day 30 post infection. The AI subsequently plateaued then declined at 20 months after diagnosis. Finally, neutralization assay to TOSV was performed in 217 sera collected from 41 patients; 69.6% of tested samples resulted in reactive and moderate levels of neutralizing antibodies observed during all phases of infection despite high titres of total anti-TOSV IgG. Conclusions: Specific antibody response develops rapidly and is long-lasting for neuroinvasive TOSV infection. Serodiagnosis of neuroinvasive TOSV requires simultaneous detection of specific IgM and IgG. Moderate levels of neutralizing antibodies were maintained over the study period, while the protective role of antibodies lacking neutralizing activity is unclear and requires further evaluation.

Details

Language :
English
ISSN :
1198743X and 14690691
Database :
OpenAIRE
Journal :
Clinical Microbiology and Infection, Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (11), pp.868-873. ⟨10.1016/j.cmi.2017.03.017⟩
Accession number :
edsair.doi.dedup.....ebcb7035395e9b9bc0b4dd54d1e94188